Discovery of most autosomal recessive disease-associated genes has involved analysis of large, often consanguineous multiplex families or small cohorts of unrelated individuals with a well-defined clinical condition. Discovery of new dominant causes of rare, genetically heterogeneous developmental disorders has been revolutionized by exome analysis of large cohorts of phenotypically diverse parentoffspring trios 1,2 . Here we analyzed 4,125 families with diverse, rare and genetically heterogeneous developmental disorders and identified four new autosomal recessive disorders. These four disorders were identified by integrating Mendelian filtering (selecting probands with rare, biallelic and putatively damaging variants in the same gene) with statistical assessments of (i) the likelihood of sampling the observed genotypes from the general population and (ii) the phenotypic similarity of patients with recessive variants in the same candidate gene. This new paradigm promises to catalyze the discovery of novel recessive disorders, especially those with less consistent or nonspecific clinical presentations and those caused predominantly by compound heterozygous genotypes.
Discovery of most autosomal recessive disease-associated genes has involved analysis of large, often consanguineous multiplex families or small cohorts of unrelated individuals with a well-defined clinical condition. Discovery of new dominant causes of rare, genetically heterogeneous developmental disorders has been revolutionized by exome analysis of large cohorts of phenotypically diverse parentoffspring trios 1,2 . Here we analyzed 4,125 families with diverse, rare and genetically heterogeneous developmental disorders and identified four new autosomal recessive disorders. These four disorders were identified by integrating Mendelian filtering (selecting probands with rare, biallelic and putatively damaging variants in the same gene) with statistical assessments of (i) the likelihood of sampling the observed genotypes from the general population and (ii) the phenotypic similarity of patients with recessive variants in the same candidate gene. This new paradigm promises to catalyze the discovery of novel recessive disorders, especially those with less consistent or nonspecific clinical presentations and those caused predominantly by compound heterozygous genotypes.
We previously noted an exome-wide excess of inherited loss-offunction variants in 1,133 individuals with undiagnosed rare developmental disorders 1 , but the recessive disorders were typically only observed in a single family 3 . This n = 1 problem for recessive disorders has been well recognized 4 . We hypothesized that, by increasing sample size, we would observe recurrent instances of both known and new recessive disorders.
Here we describe an exome analysis of 4,125 mainly simplex families with severe developmental disorders recruited through clinical genetics services in the UK and Ireland. Clinical phenotype was systematically recorded using the Human Phenotype Ontology (HPO) 5, 6 . Of these families, 1,053 had plausibly causative de novo mutations in known disease-related genes (Online Methods). To identify candidate recessive genes in the remaining 3,072 families, all rare (minor allele frequency (MAF) <1%) biallelic (homozygous or compound heterozygous) protein-altering variants were identified in each proband. We observed 74 candidate recessive genes where at least one allele was predicted to be loss of function in two or more families.
For four previously weakly implicated (described in one or two families) recessive disorders caused by variants in LARP7 (refs. 4,7), Discovery of four recessive developmental disorders using probabilistic genotype and phenotype matching among 4,125 families l e t t e r S LINS 4, 8 , PIGT 9, 10 and COL25A1 (ref. 11), we identified additional families in whom the phenotypic similarity was sufficient for us to consider that the evidence supporting these new recessive disorders is now compelling (Supplementary Table 1 ). Furthermore, we identified (DEPDC5) or confirmed (COL9A3; ref. 12 ) apparently recessive forms of dominant disorders. This phenomenon of rare recessive forms of dominant disorders has been described previously 13, 14 .
To rigorously assess the evidence supporting each candidate recessive gene, we developed a statistical approach that integrates the probabilities of sampling the observed genotypes and phenotypes by chance ( Fig. 1 and Online Methods).
We classified protein-altering variants (Online Methods and Supplementary Fig. 1 ) into two groups of predicted functional consequences: loss of function and 'functional' (protein altering but not likely to cause loss of function, for example, missense). The probability of drawing n unrelated families with similar biallelic genotypes by chance from the general population was estimated as the probability of sampling two rare alleles by chance n times from 3,072 random draws using Hardy-Weinberg rules for estimating expected genotype frequencies from allele frequencies (Online Methods). We estimated this probability separately for two classes of recessive genotype: biallelic loss-of-function alleles and compound heterozygous loss-offunction and functional alleles. First, we calculated the cumulative frequency of rare loss-of-function and missense variants using the Exome Aggregation Consortium (ExAC) data set. The gene-specific cumulative allele frequencies from the ExAC data set (European, nonFinnish ancestry) were highly concordant with the frequencies from unaffected parents (of European ancestry) (Supplementary Fig. 2) , showing that the data sets are comparable. Our method corrects for gene-specific levels of autozygosity (Supplementary Fig. 3 ) and takes account of population structure by matching each proband within the Deciphering Developmental Disorders (DDD) cohort to one of four continental populations within the ExAC data set (Online Methods). We demonstrated that our method is well calibrated by showing that the number of biallelic rare synonymous genotypes observed in probands closely follows the null distribution ( Supplementary Fig. 4) .
We estimated the probability of sampling n probands from unrelated families with observed clinical phenotypic similarity using the sum of the maximum information content (maxIC) among pairwise comparisons of the HPO terms for probands as a summary metric and comparing to a null distribution of n probands sampled randomly from among the 4,295 probands studied here (Online Methods). We demonstrated that this metric is informative by comparing probands sharing protein-altering de novo mutations in the same gene to permuted data in which the proband-gene relationship is scrambled (Supplementary Fig. 5 ).
We integrated the P values obtained from the genotypic and phenotypic assessments described above using Fisher's method (Table 1  and Supplementary Table 2 ). In effect, these analyses are testing each and every gene in the genome we can annotate (n = 17,370) under two models (biallelic loss-of-function genotype and compound heterozygous loss-of-function/functional genotype), and so we set a conservative threshold for genome-wide significance of 1.44 × 10 −6 (0.05/17,370/2). At this threshold, we identified two genes exceeding genome-wide significance, HACE1 and KIAA0586, neither of which had previously been implicated in Mendelian disease in humans.
We identified eight individuals in six families with compound heterozygosity for two apparent loss-of-function variants (n = 7) or a loss-of-function and a missense variant (n = 1) in KIAA0586 (Fig. 2) . Five of the six families had a suspected diagnosis of Joubert syndrome (MIM 213300) with a typical molar tooth sign on brain magnetic resonance images present in all but one of the affected individuals. Ataxia, hypotonia and Duane anomaly were reported features in several of the affected individuals (Supplementary Table 3) .
KIAA0586 encodes TALPID3, which is a centrosomal protein required for ciliogenesis and sonic hedgehog signaling 15 . Other genes associated with Joubert syndrome are similarly critical for cilia function 16 . Mice homozygous for a null mutation in the gene encoding Talpid3 lack cilia and are embryonic lethal, dying during organogenesis with randomized left-right patterning, typical characteristics of a ciliopathy 17 . All patients were compound heterozygous, sharing the same loss-of-function variant, p.Arg143Lysfs*4. This variant was observed at a MAF of 0.4% (383/96,534 chromosomes) in the ExAC database, more frequent than the cumulative MAF of other loss-of-function variants in KIAA0586. Therefore, we hypothesize that homozygosity for this allele is likely embryonic lethal and that our patients are compound heterozygous for a null allele and a hypomorphic allele.
We identified three individuals from three families with biallelic rare loss-of-function variants in HACE1 and an additional family with a homozygous in-frame deletion of a single codon in three affected siblings (Fig. 3) . These variants were associated with intellectual disability and significant abnormality in resting muscle tone; five of the six affected individuals had a combination of hypotonia, dystonia and spasticity. Only one (281381) of the six affected individuals was ambulant (Supplementary Table 3 ). Brain magnetic resonance images showed brain atrophy and variable hypoplasia of the corpus callosum (Fig. 3) . npg l e t t e r S HACE1 encodes a HECT domain-containing E3 ubiquitin ligase, expressed in brain. Notably, other brain-expressed HECT-domain E3 ubiquitin ligases have also been associated with intellectual disability 18 . HACE1 regulates Rac1, a small GTPase with diverse roles in signaling. A homozygous knockout mouse model of HACE1 has been described 19 that has almost complete lethality before weaning, of unknown mechanism.
We also identified four genes (MMP21, PRMT7, CSTB and COL9A3) with suggestive initial evidence (P < 1 × 10 −4 ) but not meeting genome-wide significance ( Table 1) , two of which were previously implicated recessive causes of developmental disorders (CSTB and COL9A3). We further evaluated MMP21 and PRMT7 with cosegregation studies, deeper clinical assessment and animal models and found compelling evidence for recessive causation.
We identified two individuals and one fetus from two families compound heterozygous for different loss-of-function and missense variants in MMP21, which encodes a matrix metalloproteinase (Fig. 4) . Both affected individuals and the affected fetus presented with visceral heterotaxy (situs ambiguous; MIM 306955), including complex heart malformations. The missense variants lie in close The DECIPHER ID is given above and to the left of the pedigree symbol for each affected individual recruited to the DDD study. NT indicates an unaffected individual who has not been tested for the family mutations in KIAA0586. Where available, an anterioposterior facial photograph and a transverse section from brain magnetic resonance imaging are given below the family tree. White dashed boxes and white lines indicate magnified views of the same images, illustrating the molar tooth shape of the brainstem that is considered characteristic of Joubert syndrome in families 1, 2, 4 and 5. In family 6, the brainstem shape is atypical for Joubert syndrome. The DECIPHER ID is indicated in all images. Informed consent was obtained to publish the photographs. (b) A schematic depicting the protein domain structure of TALPID3 (1,533 amino acids) encompassing the TALPID3 chain (100-1,343; in blue), which includes a highly conserved region (467-554; in orange) required for centrosomal localization and two coiled-coil domains (182-232 and 467-501; in yellow). A red asterisk (coding region variant) or dashed line (essential splice-site variant) is used to indicate the position of each pathogenic variant identified in the six families.
npg l e t t e r S proximity in the conserved zinc-binding site, with both predicted to have a major impact on enzymatic activity (Fig. 4) . Biallelic damaging variants in MMP21 have been identified in patients with heterotaxy in an independent study (companion paper 20 ).
MMP21 has been suggested to function during embryogenesis and, as a matrix metalloproteinase, may modulate cell proliferation and migration through regulating extracellular matrix remodeling 21 . Two heterotaxy mutant mouse models, Miri and Koli, were recovered from a phenotypebased mutagenesis screen with pathogenic Mmp21 missense mutations affecting the zinc-binding domain (Fig. 4) . Mutants exhibited visceral heterotaxy, with heart defects commonly associated with heterotaxy (Fig. 4) . Although heterotaxy can arise from motile cilia defects, videomicroscopy of the embryonic node showed normal cilia motility (Supplementary Video 1), suggesting that Mmp21 acts downstream of motile cilia.
We identified six affected individuals from three families with compound heterozygous loss-of-function/loss-of-function or loss-of-function/functional variants in PRMT7. The associated clinical phenotype is a phenocopy of pseudohypoparathyroidism (PHP; MIM 103580; also known as Albright hereditary osteodystrophy, or AHO). Mild intellectual disability with obesity and symmetrical shortening of the digits and posterior metacarpals and metatarsals was observed, similar to the acrodysostosis seen in PHP (Fig. 5) . Two families shared the same variant at the last base of the first coding exon, which may induce aberrant splicing rather than a missense change (p.Arg32Thr). PRMT7 encodes an arginine methyltransferase with several histone substrates 22 . Protein modeling indicated that all the observed missense variants are likely to be damaging ( Fig. 5 and Supplementary Fig. 6 ). Shortly after birth (at postnatal day (P) 10), Prmt7-knockout mice (Prmt7 tm1a/tm1a ; reporter-tagged gene-trap mice) displayed significantly reduced body size, reduced weight (−48%) and shortened fifth metatarsals (Supplementary Fig. 7 ). These mice were subviable, with only about 45% of the expected number of Prmt7 tm1a/tm1a 3 ) and dextrogastria. (e-j) Confocal episcopic microscopy shows dextrocardia with TGA for a Miri mutant (e), AVSD for a Miri mutant (f), DORV for a Koli mutant (g), dextrocardia with TGA and hypoplastic right ventricle for a Miri mutant (h), anomalous right subclavian artery from the pulmonary trunk (i) and duplicated inferior vena cava draining into bilaterally symmetric right atria, indicating right atrial isomerism (j). Ao, aorta; DA, ductus arteriosis; dAo, descending aorta; H, heart; LA, left atrium; LV, left ventricle; PA, pulmonary artery; RA, right atrium; RV, right ventricle; Stm, stomach; the prefix "m" signifies morphological. Scale bars, 0.5 mm.
pups found at P14. Surviving adult Prmt7 tm1a/tm1a mice exhibited increased fat mass, reduced length and limb bone anomalies, concordant with the human phenotypes. In addition, reduced bone mineral content and density were found in Prmt7 tm1a/tm1a mice, and early-onset osteoporosis has been observed in patients with AHO. All six affected individuals from the families were female, and, notably, the mouse model exhibited markedly sexually dimorphic phenotypes, including changes in bone mineral content, bone mineral density and fifth metacarpal length that were only significant in females ( Fig. 5 and Supplementary Table 4) . Moreover, a strong female bias has been observed in other AHO-like disorders in humans 23, 24 . Discovering rare autosomal recessive disorders is challenging, especially for genetically heterogeneous disorders in outbred populations with small families. Only a small fraction of the predicted >1,000 autosomal recessive intellectual disability disorders have been discovered 25 . New strategies for discovering novel recessive disorders are required. We have proposed the combined use of large-scale ascertainment of small families with diverse clinical presentations, exome sequencing and integrated probabilistic analysis of genotypic enrichment and phenotypic similarity. Integrating genotype and phenotype matching increased power to detect new recessive disorders while not overly penalizing the discovery of new disorders that result in variable or nonspecific clinical presentations (for example, disorders with HACE1 variants). Most (10/19) of the families we describe here with one of the six recessive disorders shown in Table 1 had a single affected child; nonetheless, these families were enriched for affected siblings in comparison to the entire cohort (P = 6.3 × 10 −5 , Poisson test), suggesting that including families with affected siblings within our cohort boosts power to detect recessive disorders.
Our method for identifying new recessive disorders requires systematic genotype and phenotype data on a known number of families and cannot be applied when collating only partial genotypic or phenotypic data on selected families. Phenotypic diversity among families is fundamental for estimating the significance of phenotypic npg l e t t e r S similarity for a given candidate gene. The power of this approach is maximal when the recording of phenotype terms is complete and consistent. For example, the statistical significance of phenotypic similarity for PRMT7 variants ( Table 1) is based on the initial HPO terms associated with individual 270360, which did not include annotation of the hand anomalies (Fig. 5) . Adding the HPO term 'short metacarpal' post hoc increases the significance of the phenotypic similarity P value considerably from 1.49 × 10 −3 to 7.00 × 10 −5 , and the combined genotypic and phenotypic P value for PRMT7 consequently becomes genome-wide significant (P = 1.97 × 10 −7 ). Unbiased clinical reevaluation of probands sharing the same candidate gene mutation will likely remain valuable.
Recruiting clinicians also recorded whether affected individuals were reminiscent of a recognized genetic syndrome, and, for three of the recessive disorders described above, the same suspected syndrome was annotated recurrently (KIAA0586, Joubert syndrome; COL9A3, Stickler syndrome; PRMT7, AHO Mouse mutants provided additional support for all four new recessive disorders described above. In principle, similarity between HPO terms and mouse mutant phenotypes 26 could be incorporated into combinatorial genotypic and phenotypic significance testing 27 . However, the current lack of consistent phenotyping data on all mouse mutants and the incomplete and biased gene coverage of mouse mutants could lead to significant biases.
Comprehensive discovery of all autosomal recessive causes of developmental disorders will require much larger data sets. Inevitably, this will necessitate international collaboration and harmonizing of phenotypic data. Adopting standard, interoperable phenotype ontologies such as HPO and, crucially, ensuring that they are applied consistently will be essential.
URLs. Exome Aggregation Consortium, http://exac.broadinstitute. org/; Picard, http://broadinstitute.github.io/picard/; spatial filtering, (c) Prmt7-knockout reporter (lacZ)-tagged mice were generated by a 'knockout-first' gene-trap strategy (SA, splice acceptor; pA, polyadenylation signal; FRT, FLP recognition target). Data were derived from mice homozygous for targeted inactivation of Prmt7 (null; Prmt7 tm1a/ tm1a ). Dual-energy X-ray absorptiometry (DEXA) scanning at 14 weeks of age indicates that female null mice have reduced bone mineral content (top left). Both male and female null mice have elevated fat mass (as a percentage of total body mass; top right) and reduced body length as determined by distance from the nose to the base of the tail (bottom right). X-ray images from 14-week-old mice show that the length of the fifth metacarpal was reduced only in female null mice. Box-and-whiskers plots show minimum-mean-maximum values. Clinical data (growth measurements, family history, developmental milestones, etc.) were collected using a standard restricted-term questionnaire within DECIPHER, and detailed developmental phenotypes for the proband are entered using HPO 5 .
Exome sequencing. Genomic DNA (approximately 1 µg) was fragmented to an average size of 150 bp and subjected to DNA library creation using established Illumina paired-end protocols. Adaptor-ligated libraries were amplified and indexed via PCR. A portion of each library was used to create an equimolar pool comprising eight indexed libraries. Each pool was hybridized to SureSelect RNA baits (6,541 samples with Agilent Human All-Exon V3 Plus with custom ELID C0338371 and 5,903 samples with Agilent Human All-Exon V5 Plus with custom ELID C0338371), and sequence targets were captured and amplified in accordance with the manufacturer's recommendations. Enriched libraries were subjected to 75-base paired-end sequencing (Illumina HiSeq) following the manufacturer's instructions.
Mapping of the short-read sequences for each sequencing lanelet was carried out using the Burrows-Wheeler Aligner (BWA; version 0.59) 28 backtrack algorithm with the GRCh37 1000 Genomes Project phase 2 reference (also known as hs37d5). PCR-and optically duplicated reads were marked using Picard (version 1.98) MarkDuplicates. Lanelets were spatially filtered to account for bubble artifacts and quality controlled (passing thresholds on the percentage of reads mapped; the percentage of duplicate reads marked; various statistics measuring indel distribution against read cycle; and an insert size overlap percentage). Lanelets were then merged into BAM files corresponding to the sample's libraries, and duplicates were marked again with Picard, after which the libraries were then merged into BAM files for each sample. Finally, samplelevel BAM improvement was carried out using the Genome Analysis Toolkit (GATK; version 3.1.1) 29 and SAMtools (version 0.1.19) 30 . This consisted of realignment of reads around known and discovered indels followed by base quality score recalibration (BQSR), with both steps performed using GATK, and, lastly, SAMtools calmd was applied and indexes were created. Known indels for realignment were taken from the Mills Devine and 1000 Genomes Project Gold set and the 1000 Genomes Project phase low-coverage set, both part of the Broad Institute's GATK resource bundle, version 2.2. Known variants for BQSR were taken from dbSNP 137, also part of the Broad Institute's resource bundle. Finally, single-nucleotide variants (SNVs) and indels were called using the GATK HaplotypeCaller (version 3.2.2); this was run in multisample calling mode using the complete data set. GATK Variant Quality Score Recalibration (VQSR) was then computed on the whole data set and applied to the individual-sample variant calling format (VCF) files.
Annotation of functional consequence. Minor allele frequency. To define the rarity of each SNV and indel, the VCF is annotated with MAF data from a variety of different sources. The MAF annotations used included data from four different populations of the 1000 Genomes Project 31 (AMR, ASN, AFR and EUR), the UK10K cohort, the NHLBI GO Exome Sequencing Project (ESP) and an internal DDD allele frequency generated using unaffected parents. For allele matching of SNVs, we used an exact match based on a key generated from four values (chromosome, position, reference allele and alternate allele). For allele matching of indels, we used a less stringent approach where the key is constructed using a different four values (chromosome, position, slice and direction). This key requires both indels to be at the same locus (chromosome and position), whereas the slice is computed on the basis of the DNA sequence difference between the reference and alternate alleles and direction is either deletion or insertion.
Variant Effect Predictor. To define the functional consequence of each variant (SNVs, indels and copy number variants (CNVs)), annotations from the Ensembl Variant Effect Predictor (VEP) 32 based on Ensembl gene build 76 were added to the VCF file. VEP produces a number of annotations, including SIFT and PolyPhen predictions, Ensembl transcripts, HGNC gene names and a prediction of the functional consequence for each variant. The transcript with the most severe consequence is selected, and all associated VEP annotations are based on the effect that the variant has on that particular transcript.
We categorized variants into two classes of variation from the VEP consequence predictions:
1. Loss of function: transcript_ablation, splice_donor_variant, splice_ acceptor_variant, stop_gained, frameshift_variant. 2. Functional: stop_lost, initiator_codon_variant, transcript_amplification, inframe_insertion, inframe_deletion, missense_variant, coding_ sequence_variant.
In addition to the standard VEP-predicted consequences, we expanded the definition of splice donor variants to include those at the neighboring last base of coding exons, if they were guanines in the reference sequence, as these bases are highly conserved within the position weight matrix of splice donor sites 33 and exhibit a skew toward rare variants-a characteristic signature of functional impact-that in unaffected DDD parents is more akin to canonical splice donor sites than missense variants (Supplementary Fig. 1 ). We identified bases in the human genome at the 3′ end of exons, where the base at that site was a guanine (specific to the strand of the transcript). Exon coordinates were obtained from GENCODE release 19 (ref. 34) , and sequences at these positions were extracted from the hs37d5 reference assembly 31 . We only included sites that overlapped synonymous or missense variants to exclude sites outside of the coding sequence.
Mendelian filtering. Of the 4,125 families recruited to the DDD study, we excluded 1,053 families from downstream recessive analyses on the basis of their having de novo mutations predicted to alter the coding sequence of genes already robustly linked to dominant or X-linked developmental disorders. For the remaining families, we identified rare (maximum MAF <1%) proteinaltering variants in the probands that were consistent with a recessive mode of inheritance. The remaining variants were either compound heterozygous variants or homozygous non-reference variants, averaging 3.2 variants per proband.
The numbers of probands in each of the functional categories (biallelic loss of function or compound heterozygous loss of function/functional) were tallied for each gene. For families with affected siblings found to share rare recessive genetic variants within a gene, only the eldest sibling was included in the tally, to have counts from independent families.
Variant filtering was conducted in Python; this analysis used version 0.2.0.
Statistical genotypic assessment. We tested all genes (coordinates from GENCODE release 19) for enrichment of rare (MAF <1%), recessive loss-offunction and functional genotypes in unrelated families. Because allele frequency can vary by population and this affects the probability of randomly observing recessive genotypes, we calculated the cumulative frequency of rare alleles in each gene from the ExAC data set, version 0.3 (accessed February 2015) in four ancestral populations: Europeans (excluding Finns), NFE; Africans, AFR; East Asians, EAS; and South Asians, SAS. Different alternate alleles at multiallelic sites were examined separately, using the most severe consequence relating to each allele. We classified each undiagnosed DDD proband into one of these four ancestral populations by projecting them onto a principalcomponent analysis of 1000 Genomes Project populations (using SNPRelate): AFR (n = 109), EAS (n = 15), NFE (n = 2,799) and SAS (n = 297). Because rare recessive genotypes are much more likely to be observed in autozygous segments (with DNA inherited from a recent common ancestor of both parents, for example, in the case of consanguinity), we used bcftools roh (version 1.0) to call autozygous segments across the entire exome and determined the number of probands autozygous across each gene of interest. We then adjusted the probability of sampling two rare loss-of-function alleles for the number of probands autozygous across each gene.
The probability of drawing n unrelated families with recessive genotypes in the same gene by chance was estimated as the binomial probability (including npg
